What are rare inherited carbohydrate metabolism disorders?

Rare inherited carbohydrate metabolism disorders are a group of medical conditions that arise from a defect in the biological process the body uses to convert carbohydrates into energy. Under normal circumstances, the digestive system utilizes specific enzymes to break down carbohydrates consumed from food into simple sugars, such as glucose, which are immediately used as fuel for cells or stored in tissues. In the presence of these inherited disorders, the body is unable to properly break down carbohydrates, either due to a deficiency of the necessary enzymes or because these enzymes do not function efficiently. This deficiency subsequently leads to an abnormal accumulation of harmful sugar substances in the body's tissues and organs, causing health complications that vary in severity, some of which may be critical or fatal [1].

Mechanism of Genetic Disorders

These disorders are inherited through genes, where a child inherits a defective copy of the gene responsible for encoding the specific enzyme from one or both parents. For example, in the case of a rare disease such as "Alpha-Mannosidosis," mutations occur in a specific gene known as (MAN2B1). This gene is responsible for the instructions for manufacturing the enzyme alpha-mannosidase. Inside the body's cells, specifically in compartments called lysosomes, this enzyme works to break down complex sugar molecules (oligosaccharides). When there is a genetic mutation, the enzyme fails to perform its task, causing these sugars to accumulate within the lysosomes, which hinders cell function and ultimately leads to cell death and tissue damage [2].

Main Types and Clinical Effects

Many diseases fall under the umbrella of carbohydrate metabolism disorders, and their clinical manifestations vary significantly:

• Mucopolysaccharidoses (MPS): This is a group resulting from the inability to break down long sugar chains (glycosaminoglycans), which are vital for building bones, cartilage, and connective tissues. The accumulation of these substances leads to progressive damage and physical changes such as short stature, coarse facial features, organ enlargement, and neurological or developmental problems [3].
• Alpha-Mannosidosis: Symptoms may appear in infancy as a severe form with rapid neurological deterioration, or as milder forms that appear later. Associated signs include muscle weakness, coordination problems (ataxia), enlargement of the liver and spleen, hearing loss, and distinct facial features such as a prominent forehead or large ears [2].

Diagnosis and Medical Care

Given the nature of these diseases, early diagnosis is the cornerstone of managing the condition. Newborns are routinely screened for some of these disorders via blood tests. For Mucopolysaccharidoses, the diagnostic journey begins with a precise clinical examination to detect sugar accumulation in the urine, followed by specialized enzymatic tests to provide a definitive diagnosis [3]. Genetic testing is also available for couples with a family history to assess the likelihood of passing the disease to offspring or to detect the condition in the fetus.

Regarding therapeutic management, there is currently no radical or curative treatment for all these disorders, but available interventions aim to alleviate symptoms and slow functional deterioration. Treatment plans include customized diets, supplements, and supportive medications. It must be noted that every case differs from another, requiring continuous follow-up with specialized physicians to adjust the treatment plan according to the patient's health developments. For more details on how to manage these conditions, you can read our article on Rare Inherited Carbohydrate Metabolism Disorders: Diagnosis, Treatment, and Coexistence (Arabic).

Medical references

• Carbohydrate Metabolism Disorders
• Alpha-mannosidosis
• Mucopolysaccharidoses